Article
Switching from prasugrel to clopidogrel based on Cytochrome P450 2C19 genotyping in East Asian patients stabilized after acute myocardial infarction.
Platelets - 1 Jun 2016
Lee Ji Hyun, Ahn Sung Gyun, Lee Jun-Won, Youn Young Jin, Ahn Min-Soo, Kim Jang-Young, Yoo Byung-Su, Lee Seung-Hwan, Yoon Junghan, Kim Juwon, Choi Eunhee, Yoo Sang-Yong, Hung Olivia Y, Samady Habib
Abstract excerpt
To evaluate the pharmacodynamic efficacy of de-escalating P2Y12 inhibition from prasugrel to clopidogrel based on cytochrome P450 (CYP) 2C19 genotyping, we genotyped 50 Korean patients with AMI who underwent percutaneous coronary intervention (PCI) for CYP2C19 *2,*3, or *17 using real-time PCR. They were discharged on prasugrel 10 mg daily. A control group of 48 AMI patients who underwent PCI and were discharged...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
